InvestorsHub Logo
Followers 3156
Posts 961293
Boards Moderated 204
Alias Born 09/04/2000

Re: pivotpoint1 post# 1867

Thursday, 03/26/2020 10:48:51 AM

Thursday, March 26, 2020 10:48:51 AM

Post# of 2719
$OPGN Multiple Catalyst! $25 PT
1. Merger with Curetis/Ares approved date 3/30
2.Ares/ Curetis offering COVID-19 test kit by BGI in EU, Middle East, Africa market. five figure orders qty, 20%-40% margin
3. Partners Qiagen Sandoz BGI Merck ThermoFisher
4.Acuitas Lighthouse revenue up 147% in 2019
5.OpGen working with FDA 510k Acuitas Isolates, labeling, FDA pending $25m Potential
6.Patient accrual underway since 12/19, the Acuitas Urine for UTI, FDA De Novo clearance trial.2nd qtr $100m potential
7.Achievement of NY State Infectious Disease project. More states?
8.Curetis/BCB agreement on bringing Unyvero to China pending their FDA, approval 1st qtr '20 $150m euro
9.FY2020 estimated revenue $15m doesn't include many catalyst
10.Ares R&D contract with undisclosed leading global IVD Corp to develop diagnostic solutions for infectious disease testing
11.Curetis launch of FDA cleared Unyvero BAL available in US since 1/20
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent OPGN News